MATTHEW M BROWN, MD
Physical Therapy at Nine Mound Rd, Madison, WI

License number
Wisconsin 11468
Category
Restorative Service Providers
Type
Physical Therapist
Address
Address
100 N Nine Mound Rd, Madison, WI 53593
Phone
(608) 845-9531
(608) 845-8684 (Fax)

Professional information

Matthew Brown Photo 1

Associate At Michael Best And Friedrich

Location:
Madison, Wisconsin Area
Industry:
Law Practice
Work:
Michael Best and Friedrich Jan 2010 - Aug 2012 - Intellectual Property Litigation Associate
Education:
University of Iowa College of Law 2006 - 2009
Juris Doctor, Law
University of Iowa 2002 - 2006
B.S.E., Industrial Engineering


Matthew Brown Photo 2

Accounts Payable/General Cashier At Hilton Madison Monona Terrace

Position:
Accounts Payable/General Cashier at Hilton Madison Monona Terrace
Location:
Madison, Wisconsin Area
Industry:
Hospitality
Work:
Hilton Madison Monona Terrace since Jun 2011 - Accounts Payable/General Cashier Sheraton Mar 2007 - Jun 2011 - Credit Manager & A/R Manager


Matthew Brown Photo 3

Matthew Brown - Madison, WI

Work:
Agrace Hospice Care, Inc
Accounts Payable Specialist
Agrace Hospice Care, Inc
Accounting Assistant
Certegy Financial Services - mad
Settlement and Research Representative
Education:
UW-LaCrosse
Bachelor of Science in Economics


Matthew Brown Photo 4

Matthew Brown

Location:
Madison, Wisconsin Area
Industry:
Biotechnology


Matthew Brown Photo 5

Reprogramming T Cells And Hematopoietic Cells

US Patent:
2012013, May 31, 2012
Filed:
Jun 4, 2010
Appl. No.:
13/376361
Inventors:
Matthew Brown - Madison WI, US
Elizabeth Rondon Dominguez - Madison WI, US
Randy Learish - Oregon WI, US
Emile Nuwaysir - Madison WI, US
Deepika Rajesh - Madison WI, US
Amanda Mack - Madison WI, US
International Classification:
C12N 5/071, C12N 15/85, C12N 15/86, C12N 5/02
US Classification:
435455, 435366, 435377
Abstract:
Methods and compositions relating to the production of induced pluripotent stem cells (iPS cells) are disclosed. For example, induced pluripotent stem cells may be generated from CD34 hematopoietic cells, such as human CD34 blood progenitor cells, or T cells. Various iPS cell lines are also provided. In certain embodiments, the invention provides novel induced pluripotent stem cells with a genome comprising genetic rearrangement of T cell receptors.